Comparison of Cytotoxic Activity against Gastrointestinal Cancer Cell Lines of Basella alba L. and Basella rubra L. Extracts

Main Article Content

Yanisa Ruaysup
Srisopa Ruangnoo
Arunporn Itharat

Abstract

Introduction and objective: Basella alba L. and B. rubra L. (phak plang in Thai) are medicinal plants in many Asian countries, and they have been traditionally used as food and traditional medicine for treatments of constipation and peptic ulcer. This study aimed to investigate and compare cytotoxic activity against gastrointestinal cancer cell lines of B. alba and B. rubra extracts.


Methods: The extractions of B. alba and B. rubra were undertaken by maceration with 95% ethanol and then by the partition extraction method. All extracts were examined for cytotoxic activity against gastrointestinal cancer cell lines namely oral epidermoid carcinoma (KB), gastric carcinoma (KATO III), colorectal adenocarcinoma (SW480 and LS 174T), cholangiocarcinoma (KKU-M156), and hepatocellular carcinoma (Hep G2), and normal cell lines including HaCat (immortal human epidermal keratinocytes) by SRB assay.


Results: The B. alba crude extract showed higher cytotoxic activity against gastrointestinal cancer cell lines than B. rubra. The B. alba crude extract showed cytotoxic activity against KB, KATO III, SW480 and KKU-M156 cell lines with IC50 of 39.31, 33.82, 31.54, 33.79 µg/mL, respectively, while LS 174T, and Hep G2 cell lines with IC50 of 63.06 and 59.63 µg/mL. The B. alba crude extract also showed the highest selectivity index (SI) between HaCaT cell lines against cancer cell lines including KB, KATO III, SW480, and KKU-M156 with SI of 2.39, 2.78, 2.98, and 2.79, respectively. In addition, the chloroform mix ethyl acetate fraction of ethanolic extract of fresh B. alba showed good cytotoxic activity against KB, KATO III, LS 174T, KKU-M156, and HepG2 cell lines except the SW480 cell lines, that the chloroform fraction of ethanolic extract of fresh B. rubra had higher activity. Interestingly, the chloroform fraction of ethanolic extract of fresh B. rubra showed an SI value better than B. rubra.


Discussion: This research aimed to investigate and compare of cytotoxic activity against gastrointestinal cancer cell lines of B. alba and B. rubra extracts by SRB assay. The results showed that the B. alba crude extract had more potent cytotoxic activity (SI > 2) against gastrointestinal cancer cells than B. rubra and showed moderate cytotoxic activity against KB, KATO III, SW480 and KKU-M156 cell lines, as established by NCI. Further extraction found that the chloroform fraction of B. rubra crude extract had potent cytotoxic activity against KATO III, SW480, KKU-M156, and LS 174T about 3–6 times more than the B. alba crude extract.


Conclusion and recommendation: The extraction of B. rubra by maceration with 95% ethanol and fractionated with chloroform showed the best potential cytotoxic activity against gastrointestinal cancer cells. These results provide basic information about the biological activity including cytotoxic activity against gastrointestinal cancer of Basella species extracts. However, further investigations on chemical markers, in vivo pharmacological activity testing, and toxicity testing are needed for future development as a product.

Article Details

Section
Original Articles
Author Biography

Srisopa Ruangnoo, Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University, Klong Nueng Sub-District, Klong Luang District, Pathum Thani 12120, Thailand

สถานการแพทย์แผนไทยประยุกต์ คณะแพทยศาสตร์ มหาวิทยาลัยธรรมศาสตร์ ตำบลคลองหนึ่ง อำเภอคลองหลวง จังหวัดปทุมธานี 12120

Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University, Klong Nueng Sub-District, Klong Luang District, Pathum Thani 12120, Thailand

References

World Health Organization. Thailand Source: Globocan 2020. [Internet]. 2021 [cited 2021 Mar 5]; Available from: https://gco.iarc.fr/today/data/factsheets/populations/764-thailand-fact-sheets.pdf.

National Cancer Institute. Hospital-based cancer registry 2021 [Internet]. 2022 [cited 2023 Jan 17]; Available from: https://www.nci.go.th/e_book/hosbased_2564/index.html.

Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335-49.e15.

American Cancer Society. Colorectal cancer. [Internet]. 2021 [cited 2021 Jan 12]; Available from: https://www.cancer.org/cancer/colon-rectal-cancer.html.

Chatchawal C, Nualkaew N. Ceylon Spinach (L.), a nutritious local vegetable with potential for health food production. J Thai Trad Alt Med. 2009;7(2-3):197–201. (in Thai)

Kumar V, Bhat Z, Kumar D, Khan N, Chashoo IA, Ara I. Gastroprotective effect of leaf extracts of Basella alba var. alba against experimental gastric ulcers in rats. Rev. Bras. Farmacogn. 2012;22:657–62.

Jaiswal SK, Rao CV. Evaluation of standardized fractions of Basella alba leaves as gastroprotective activity on ulcerated rats. Orient Pharm Exp Med. 2016;16:339–47.

Deshmukh S, Gaikwad D. A review of the taxonomy, ethnobotany, phytochemistry and pharmacology of Basella alba (BASELLACEAE). J Appl Pharm Sci. 2014;4(1):153–65.

Glassgen WE, Metzger JW, Heuer S, Strack D. Betacyanins from fruits of Basella rubra. Phytochemistry. 1993;33(6):1525–7.

Kumar S, Prasad A, Iyer S, Vaidya S. Systematic pharmacognostical, phytochemical and pharmacological review on an ethno medicinal plant, Basella alba L. J. Pharmacogn. Phytotherapy. 2013;5(4):53–8.

Murakami T, Hirano K, Yoshikawa M. Medicinal foodstuffs. XXIII. 1) structures of new oleanane-type triterpene oligoglycosides, basellasaponins A, B, C, and D, from the fresh aerial parts of Basella rubra L. Chem Pharm Bull. 2001;49(6):776–9.

Abotaleb M, Liskova A, Kubatka P, Büsselberg D. Therapeutic potential of plant phenolic acids in the treatment of cancer. Biomolecules. 2020;10(2):221.

Abotaleb M, Samuel SM, Varghese E, Varghese S, Kubatka P, Liskova A, Busselberg D. Flavonoids in cancer and apoptosis. Cancers. 2018;11(1):28.

Kanner J, Harel S, Granit R. Betalains a new class of dietary cationized antioxidants. J. Agric. Food Chem. 2001;49(11):5178–85

Kopustinskiene DM, Jakstas V, Savickas A, Bernatoniene J. Flavonoids as anticancer agents. Nutrients. 2020;12(2):457.

Olajire A, Azeez L. Total antioxidant activity, phenolic, flavonoid and ascorbic acid contents of Nigerian vegetables. Afr. J. Food Sci.Technol. 2011;2(2):22-9.

Oluwakemi OA, Akindele AJ, Bosede FS. Ascorbic acid, total phenolic, flavonoid and antioxidant activity of two cultivars of Basella alba. Food Sci. Technol. 2017;5(4):92–6.

Maisuthisakul P, Pasuk S, Ritthiruangdej P. Relationship between antioxidant properties and chemical composition of some Thai plants. J. Food Compos. Anal. 2008;21(3):229–40.

Venkatalakshmi P, Senthamaraiselvi V. Anti-ulcer effect of Basella alba leaf extract in aspirin induced albino rats. Int J Pharm Sci Res. 2012;3(8):2539.

Kumar BR, Anupam A, Manchikanti P, Rameshbabu AP, Dasgupta S, Dhara S. Identification and characterization of bioactive phenolic constituents, anti-proliferative, and anti-angiogenic activity of stem extracts of Basella alba and rubra. J Food Sci Technol. 2018;55:1675-84.

Pal K. Cell growth inhibition and apoptosis by extract of Basella alba plant on U937 cells. World J. Pharm. Pharm. Sci. 2015;5:1251–61.

Islam MS, Rahi MS, Jahangir CA, Rahman MH, Jerin I, Amin R, Hoque KMF, Reza MA. In vivo anticancer activity of Basella alba leaf and seed extracts against Ehrlich’s ascites carcinoma (EAC) cell line. Evid Based Complement Alternat Med. 2018;2018.

Rodda R, Kota A, Sindhuri T, Kumar SA, Gnananath K. Investigation on anti-inflammatory property of Basella alba linn leaf extract. Int J Pharm Pharm Sci. 2012;4(1):452-4.

Haneefa MKP, Abraham A, Saraswathi R, Mohanta GP, Nayar C. Formulation and Evaluation of Herbal Gel of Basella alba for wound healing activity. J. Pharm. Sci. & Res. 2010;4(1):1642-8.

Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82(13):1107–12.

Itharat A, Houghton PJ, Eno-Amooquaye E, Burke P, Sampson JH, Raman A. In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer. J Ethnopharmacol. 2004;90(1):33–8.

Suffness M. Assays related to cancer drug discovery. Methods in plant biochemistry: assays for bioactivity. 1990;6:71–133.

Peña-Morán OA, Villarreal ML, Álvarez-Berber L, Meneses-Acosta A, Rodríguez-López V. Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines. Molecules. 2016;21(8):1013.

Indrayanto G, Putra GS, Suhud F. Validation of in-vitro bioassay methods: Application in herbal drug research. Profiles of Drug Substances, Excipients and Related Methodology. 2021;46:273-307.

Kilari BP, Kotakadi VS, Penchalaneni J. Anti-proliferative and apoptotic effects of Basella rubra (L.) against 1, 2-dimethyl hydrazine-induced colon carcinogenesis in rats. J. Asian Pac J Cancer Prev. 2016;17(1):73–80.

Lyu JI, Ryu J, Seo KS, Kang KY, Park SH, Ha TH, Ahn JW, Kang SY. Comparative study on phenolic compounds and antioxidant activities of hop (Humulus lupulus L.) strobile extracts. Plants. 2022;11(1):135.